Share：
Share this content in WeChat
X
[Chinese][PDF]991120
• Experience Exchanges •
Predictive effect of Gd-EOB-DTPA enhanced MRI for HBV-related diameter ≤ 1 cm sHCC intrahepatic metastasis
LI Xueqin  PAN Ziang  WANG Xing  ZHAO Dawei  LIN Dongdong  YANG Guang  LIU Hui  REN Meiji  XIA Zhenying  LI Hongjun  LI Dechun 

Cite this article as: Li XQ, Pan ZA, Wang X, et al. Predictive effect of Gd-EOB-DTPA enhanced MRI for HBV-related diameter ≤1 cm sHCC intrahepatic metastasis[J]. Chin J Magn Reson Imaging, 2021, 12(6): 97-101. DOI:10.12015/issn.1674-8034.2021.06.019.


[Abstract] Objective To explore the predictive effect of Gd-EOB-DTPA (Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid, Gd-EOB-DTPA) enhanced MRI for metastasis of hepatocellular carcinoma (HCC) with diameter ≤1 cm. Materials andMethods Forty-five patients (median age 55 years old, male 71.1%) without intrahepatic metastasis, without tumor embolus in portal vein trunk and primary branch, with sufficient incisal margin and diameter of ≤1 cm were followed up for a median time of 13 months, and were divided into metastatic group (n=15) and non-metastatic group (n=30) according to whether HCC intrahepatic metastasis occurred. Clinical and imaging characteristics between two groups were compared and risk factors of HCC intrahepatic metastasis were determined by univariate Kaplan-Meier analysis and multivariate Cox regression.Results Compared with the non-metastatic group, HCC with intrahepatic metastasis in the early stage of Gd-EOB-DTPA enhanced MRI images was likely to show hypointensity on T1WI (9/60.0%, P=0.042), hyperintensity on DWI (12/80.0%, P＜0.001), homogeneous enhancement in the arterial phase (10/66.7% P=0.017), hypointensity in transitional (12/80.0%, P=0.001) and hepatobiliary phase (9/60.0%, P=0.016); minimal signal ＞1/2 in hepatobiliary phase (14/93.3%,P＜0.001). After adjusting for age, sex, differentiation grade, Edmondson grade in the multivariate Cox model, hypointensity in transitional phase (HR=6.19, 95% CI: 1.73—22.16, P=0.005) was independent risk factor for HCC intrahepatic metastasis.Conclusions Gd-EOB-DTPA enhanced MRI has advantages in predicting intrahepatic metastasis of HCC lesions with a diameter ≤1 cm. It can provide support for the formulation of therapeutic regimen as soon as possible.
[Keywords] Gd-EOB-DTPA；magnetic resonance imaging；hepatocellular carcinoma；intrahepatic metastasis

LI Xueqin1   PAN Ziang2   WANG Xing1   ZHAO Dawei1   LIN Dongdong1   YANG Guang1   LIU Hui1   REN Meiji1   XIA Zhenying1   LI Hongjun1   LI Dechun3*  

1 Youan Hospital Affiliated of Capital Medical University, Beijing 100069, China

2 Peking Union Medical College & Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing 100730, China

3 Xuzhou Central Hospital, Xuzhou 221009, China

Li DC, E-mail: 18952171358@189.cn

Conflicts of interest   None.

Received  2021-02-04
Accepted  2021-03-29
DOI: 10.12015/issn.1674-8034.2021.06.019
Cite this article as: Li XQ, Pan ZA, Wang X, et al. Predictive effect of Gd-EOB-DTPA enhanced MRI for HBV-related diameter ≤1 cm sHCC intrahepatic metastasis[J]. Chin J Magn Reson Imaging, 2021, 12(6): 97-101. DOI:10.12015/issn.1674-8034.2021.06.019.

1
Kim BR, Lee JM, Lee DH, et al. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging versus multidetector CT in the detection of dysplastic nodules and early hepatocellular carcinoma[J]. Radiology, 2017, 285(1): 134-146. DOI: 10.1148/radiol.2017162080.
2
Hope TA, Aslam R, Weinstein S, et al. Change in liver imaging reporting and data system characterization of focal liver lesions Using gadoxetate disodium magnetic resonance imaging compared with contrast—enhanced computed tomography[J]. J Comput Assisted Tomography, 2017, 41(3): 376-381. DOI: 10.1097/RCT.0000000000000536.
3
Imbriaco M, De Luca S, Coppola M, et al. Diagnostic accuracy of Gd-EOB-DTPA for detection hepatocellular carcinoma (HCC): A comparative study with dynamic contrast enhanced magnetic resonance imaging (MRI) and dynamic contrast enhanced computed tomography (CT)[J]. Pol J Radiol, 2017, 82(1): 50-57. DOI: 10.12659/PJR.899239.
4
Hermanek P, Hutter RVP, Sobin LH, et al. International union against cancer. Classification of isolated tumor cells and micrometastasis[J]. Cancer, 1999, 86(3): 2668-2673. DOI: 10.1002/(SICI)1097-0142.
5
Kobayashi A, Miyagawa S, Miwa S, et al. Prognostic impact of anatomical resection on early and late intrahepatic recurrence in patients with hepatocellular carcinoma[J]. J Hepatobiliary Pancreatic Surg, 2008, 15(5): 515-521. DOI: 10.1007/s00534-007-1293-7.
6
Zhang XQ, Lu J, Zhang T, et al. The value of gadolinium disodium- enhanced T1 mapping imaging in evaluating liver function[J]. Chin J Radiol, 2018, 52(1): 30-35. DOI: 10.3760/cmaj.i.ssn.1005-1201.2018.01.007.
7
Chen GY, Tang HH, Liu YY, et al. To explore the optimal delay time of Gd-EOB-DTPA in MRI biliary tract imaging[J]. Radiol Pract, 2016, 31(1): 30-34. DOI: 10.13609/j.cnki.1000-0313.2016.01.008.
8
Inchingolo R, Faletti R, Grazioli L, et al. MR with Gd-EOB-DTPA in assessment of liver nodules in cirrhotic patients[J]. World J Hepatol, 2018, 10(7): 462-473. DOI: 10.4254/wjh.v10.i7.462.
9
Jiang JY, Li XS, Ma KS. Application of gadoxetate disodium in preoperative evaluation of hepatobiliary surgery[J]. J Clin Hepatol, 2015, 31(6): 996-998. DOI: 10.3969/j.issn.1001-5256.201.06.042.
10
Kim BR, Lee JM, Lee DH, et al. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging versus multidetector CT in the detection of dysplastic nodules and early hepatocellular carcinoma[J]. Radiology, 2017, 285(1): 134-146. DOI: 10.1148/radiol.2017162080.
11
Inchingolo R, Faletti R, Grazioli L, et al. MR with Gd-EOB-DTPA in assessment of liver nodules in cirrhotic patients[J]. World J Hepatology, 2018, 10(7): 462-473. DOI: 10.4254/wjh.v10.i7.462.
12
Getzin T, Gueler F, Hartleben B, et al. Gd-EOB-DTPA MRI for quantitative assessment of liver organ damage after partial hepatic ischaemia reperfusion injury: correlation with histology and serum biomarkers of liver cell injury[J]. Eur Radiol, 2018, 28(10): 4455-4464. DOI: 10.1007/s00330-018-5380-8.
13
Kumada T, Toyoda H, Tada T, et al. Evolution of hypointense hepatocellular nodules observed only in the hepatobiliary phase of gadoxetate disodium-enhanced MRI[J]. Am J Roentgenol, 2011, 197(1): 58-63. DOI: 10.2214/AJR.10.5390.
14
Guo TC, Wu CY, Wen YX, et al. Preliminary study on the correlation between Gd-EOB-DTPA enhanced MRI of hepatocellular carcinoma and pathological grade[J]. Chin J CT & MRI, 2018, 16(3): 63-65. DOI: 10.3969/j.issn.1672-5131.2018.03.020.
15
Asayama Y, Tajima T, Nishie A, et al. Uptake of Gd-EOB-DTPA by hepatocellular carcinoma: Radiologic–pathologic correlation with special reference to bile production[J]. Eur J Radiol, 2011, 80(3): e243-e248. DOI: 10.1016/j.ejrad.2010.10.032.
16
Narita M, Hatano E, Arizono S, et al. Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma[J]. J Gastroenterol, 2009, 44(7): 793-798. DOI: 10.1007/s00535-009-0056-4.
17
Tsuboyama T, Onishi H, Kim T, et al. Hepatocellular carcinoma: Hepatocyte-selective enhancement at gadoxetic acid–enhanced MR imaging—correlation with expression of sinusoidal and canalicular transporters and bile accumulation[J]. Radiology, 2010, 255(3): 824-833. DOI: 10.1148/radiol.10091557.
18
Kitao A, Zen Y, Matsui O, et al. Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR imaging -correlation with molecular transporters and histopathologic features[J]. Radiology, 2010, 256(3): 817-826. DOI: 10.1148/radiol.10092214.
19
Kudo M, Tochio H. Intranodular blood supply correlates well with biological malignancy grade determined by tumor growth rate in pathologically proven hepatocellular carcinoma[J]. Oncology, 2008, 75(1): 55-64. DOI: 10.1159/000173425.
20
Wang B, Gao ZQ, Yan X. Correlative study of angiogenesis and dynamic contrast-enhanced magnetic resonance imaging features of hepatocellular carcinoma[J]. Acta Radiol, 2005, 46(4): 353-358. DOI: 10.1177/0300060521997586.
21
Doo KW, Lee CH, Choi JW, et al. "Pseudo wash-out" sign in high-flow hepatic hemangioma on gadoxetic acidcontrast-enhanced MRI mimicking hypervascular tumor[J]. AJR Am J Roentgenol, 2009, 193(6): W490-W496. DOI: 10.2214/AJR.08.1732.
22
Park YS, Lee CH, Kim JW, et al. Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: what are the tips when using hepatocyte-specific agents?[J]. World J Gastroenterol, 2016, 22(1): 284-299. DOI: 10.3748/wjg.v22.i1.284.
23
Lee Y, Kim SY, Lee SS, et al. Pitfalls in Gd-EOB-DTPAenhanced liver magnetic resonance imaging with an emphasis on nontumorous lesions[J]. Clin Liver Dis (Hoboken), 2018, 12(2): 50-59. DOI: 10.1002/cld.723.
24
Choi SH, Lee SS, Park SH, et al. LI-RADS classification and prognosis of primary liver cancers at Gadoxetic acid-enhanced MRI[J]. Radiology, 2019, 290(2): 388-397. DOI: 10.1148/radiol.2018181290.
25
Fujita N, Nishie A, Asayama Y, et al. Hyperintense liver masses at hepatobiliary phase Gadoxetic acid-enhanced MRI: imaging appearances and clinical importance[J]. Radiographics, 2020, 40(1): 72-94. DOI: 10.1148/rg.2020190037.

PREV The application of MRI guided breast localization and biopsy in breast lesions
NEXT Imaging features of multi-mode multi-parameter magnetic resonance imaging in the diagnosis of placenta accreta
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn